Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism
Mots clés
Animals
Antiparkinson Agents/*therapeutic use
Behavior/drug effects
Catalepsy/chemically induced/drug therapy
Cell Line
Disease Models
Animal
Electrophysiological Phenomena
Globus Pallidus/drug effects/physiopathology
Haloperidol/pharmacology
Humans
Mice
Inbred C57BL
Parkinsonian Disorders/*drug therapy/*physiopathology
Rats
Receptors
Metabotropic Glutamate/*agonists
Synaptic Transmission/drug effects